نتائج البحث

A Phase 1/2/3 Study to Evaluate the Safety, Tolerability, and Efficacy of VX-880 in Subjects Who Have Type 1 Diabetes Mellitus With Impaired Hypoglycemic Awareness and Severe Hypoglycemia قائمة الدراسات السريرية المسجلة على الادوية

Phase 3 Randomized Study Comparing Talquetamab in Combination with Pomalidomide (Tal-P), Talquetamab in Combination with Teclistamab (Tal-Tec), and Investigator’s Choice of Either Elotuzumab, Pomalidomide, and Dexamethasone (EPd) or Pomalidomide, Bortezomib, and Dexamethasone (PVd) in Participants with Relapsed or Refractory Myeloma who Have Received 1 to 4 Prior Lines of Therapy Including an Anti-CD38 Antibody and Lenalidomide قائمة الدراسات السريرية المسجلة على الادوية

A Phase 2 Study for the Treatment of Anemia with Alpha (α)-Thalassemia to Determine the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) in Adults and Evaluate the Safety and Pharmacokinetics in Adolescents قائمة الدراسات السريرية المسجلة على الادوية

Iron/ Pantothenic acid/ vit E/ vit B12/ vit C/ folic acid/ copper/ malt extract/ flax feed/ zinc/ vit B2/ vit A/ vit B1/ vit B6/ vit B3/ DSM-UK قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

The ENERGY 3 Study: A Randomized, Controlled, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Children with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency قائمة الدراسات السريرية المسجلة على الادوية

The ENERGY 2 Study: An Open-Label Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Infants with Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency قائمة الدراسات السريرية المسجلة على الادوية

A 3 Month, Multicenter, Double-Masked Safety and Efficacy Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients قائمة الدراسات السريرية المسجلة على الادوية

Phase 3, open label, single arm study to evaluate efficacy and safety of FIX gene transfer with PF-06838435 (rAAV-Spark100-hFIX-Padua) in adult male participants with moderately severe to severe hemophilia B (FIX:C<2%) (BeneGene-2) قائمة الدراسات السريرية المسجلة على الادوية

A Phase 2/3, Open-Label, Randomized, Controlled, Multicenter Study of KYV-101, an Autologous Fully Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, Versus Ongoing Standard-Of-Care Immunosuppressive Therapy in Patients with Generalized Myasthenia Gravis (KYSA-6). قائمة الدراسات السريرية المسجلة على الادوية

Omega-3 Acid Ethyl ester- EPA-36 percent and DHA-24 percent Equivalent to EPA 180 mg and DHA 120 mg/ Sea Buckthorn Seed Oil/ Astaxanthin 5 percent Oil قائمة الأدوية تحت التسجيل / قائمة الأدوية المعروضة على لجنة التسجيل

عرض 931 - 940 من 1933